Our finding that anti‐GA vaccination also rescues the level of cytoplasmic TPD‐43 suggests that targeting a single component may be sufficient to delay or even stop disease progression in C9orf72‐associated ALS/FTD. This evidence concerns the gene C9orf72 and frontotemporal dementia.